Here's why the Volpara (ASX:VHT) share price is up 6% today

The Volpara (ASX: VHT) share price is gaining today after the company released its quarterly results. Let's take a look.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Volpara Health Technologies Ltd (ASX: VHT) shares are gaining today after the company released its quarterly results. At the time of writing, the Volpara share price is up 6.25%, trading at $1.36 apiece.

Volpara is a health technology software company, providing an integrated breast care platform to deliver personalised breast care. Let's take a closer look at the New Zealand-based company's latest results.

Medical staff wear hero capes, indicting strong shar [price performace for healthcare shares

Image source: Getty Images

Fourth-quarter results

The company released its results for the fourth quarter of the 2021 financial year this morning, garnering a positive reaction from investors.

Good news from the company included a record cash income from customer receipts, equalling NZ$5.4 million. That figure represents a 15% increase compared to the fourth quarter of 2020.

The company's subscription-based receipts were also up, raking in NS$18.3 million – a 39% year on year increase.

Volpara also announced increases in its unaudited cash receipts for the full year ending 31 March 2021, up 20% year on year.

Its net operating cash outflow was better than the company's internal forecasting, and it ended the quarter with $32.2 million cash in the bank.

Volpara's earnings before interest, tax, depreciation and amortisation (EBITDA) came in at a loss of NZ$3,432,000.

Today is the second time Volpara's share price has reacted positively to its results for this quarter. On 20 April, the Volpara released a business update on the fourth quarter, which also saw its share price rise.

Unfortunately, its gains didn't hold that day, and the Volpara share price ended the session trading 4.2% lower than the previous close.

Commentary from management

Volpara CEO Dr Ralph Highnam commented on the results, saying:

Our achievements in [the 2021 financial year] are a powerful endorsement of what we stand for as a company and the strength and commitment of our industry to keep saving families from cancer, no matter what else is going on.

We look forward to continuing to accelerate out of COVID-19 in [the 2022 financial year].

Volpara share price snapshot

Currently, the Volpara share price is down 3% year to date, although it's up 8% over the last 12 months.

The company has a market capitalisation of around $321 million, with approximately 251 million shares outstanding.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends VOLPARA FPO NZ. The Motley Fool Australia has recommended VOLPARA FPO NZ. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A man wearing a white coat holds his hands up and mouth open with joy.
ASX Share Market News

Healthcare shares lead the ASX 200 again as sector rotation gathers pace

The sector is up 20% in just a month as value investors swoop on blue-chip favourites like CSL.

Read more »

A doctor shrugs and holds his hands out.
Healthcare Shares

CSL shares are up 25%: is it time to buy, hold or sell?

CSL's recovery could be well underway, but analysts remain far from convinced.

Read more »

Three people jumping cheerfully in clear sunny weather.
Healthcare Shares

This ASX biotech stock is tipped to double or even triple in value

Is this one of the ASX's most overlooked biotech opportunities?

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Healthcare Shares

Cochlear shares have jumped 23% in a month: Is there more upside ahead?

Cochlear shares have erased part of their recent losses, but there is a long way to go until they return…

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Up 55% in 2026! Why this ASX healthcare stock is climbing again

This ASX healthcare stock is extending its strong 2026 run.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

Up more than 550% in a year, why is this ASX biotech charging even higher?

AI is at the heart of the recently announced deal.

Read more »

Male wearing face mask reviewing medical scans on light box.
Healthcare Shares

This ASX healthcare stock is jumping 15% today. Here's why

This ASX healthcare stock is up 15% after a US update.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

Top 3 ASX healthcare stocks to buy today

CSL, ResMed, and Pro Medicus have all fallen heavily in 2026. Here is why these three ASX healthcare stocks are…

Read more »